Published in Virology on April 01, 1971
Structural proteins of mammalian oncogenic RNA viruses: multiple antigenic determinants of the major internal protein and envelope glycoprotein. J Virol (1974) 3.91
Radioimmunoassay of mammalian type-C viral proteins: interspecies antigenic reactivities of the major internal polypeptide. Proc Natl Acad Sci U S A (1972) 2.90
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. II. Mammalian leukemia-sarcoma viruses. J Virol (1972) 2.84
Purification and immunological characterization of the major internal protein of the RD-114 virus. Proc Natl Acad Sci U S A (1972) 1.92
Interspecies antigenic determinants of the reverse transcriptases and p30 proteins of mammalian type C viruses. J Virol (1975) 1.64
Properties of feline leukemia virus. I. Chromatographic separation and analysis of the polypeptides. J Virol (1974) 1.51
Antigen related to mammalian type-C RNA viral p30 proteins is located in renal glomeruli in human systemic lupus erythematosus. Proc Natl Acad Sci U S A (1976) 1.18
Structural proteins of mammalian RNA tumor viruses: relatedness of the interspecies antigenic determinants of the major internal protein. J Virol (1975) 1.06
Studies on FeSV induced sarcomata in sheep with particular reference to the regional lymphatic system. Br J Cancer (1975) 0.88
Immunological cross-reactions between two low-molecular-weight polypeptides from a murine type C virus. J Virol (1974) 0.81
Murine virus-induced proteins synthesized by hamster tumor cells transformed by, but not producing, murine sarcoma virus. J Virol (1974) 0.77
Effect of urea on the hemagglutinating and complement-fixing antigens of type 2 Dengue virus. Infect Immun (1972) 0.77
Counter-immunoelectrophoresis: rapid method for detecting group-specific antigen and antibodies associated with oncogenic ribonucleic acid viruses. Appl Microbiol (1971) 0.75
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A (1986) 8.48
Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc Natl Acad Sci U S A (1988) 7.74
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature (1998) 7.55
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci U S A (1989) 6.58
A novel murine oncornavirus with dual eco- and xenotropic properties. Proc Natl Acad Sci U S A (1975) 5.91
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Proc Natl Acad Sci U S A (1986) 5.55
A proposed nomenclature for the virion proteins of oncogenic RNA viruses. Virology (1974) 5.01
Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci U S A (1986) 4.68
Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science (1990) 4.43
Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. J Virol (1988) 4.13
Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids. Nat New Biol (1971) 3.95
Assembly of type C oncornaviruses: a model. Science (1978) 3.53
The b alleles of U. maydis, whose combinations program pathogenic development, code for polypeptides containing a homeodomain-related motif. Cell (1990) 3.48
Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc Natl Acad Sci U S A (1987) 3.47
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J Infect Dis (1997) 3.35
A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion. J Virol (1995) 3.11
Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc Natl Acad Sci U S A (1997) 3.02
Localization of RNA tumor virus polypeptides. I. Isolation of further virus substructures. Virology (1973) 2.94
Experimental transmission of feline fibrosarcoma to cats and dogs. Nature (1970) 2.91
A transmissible virus-induced lymphocytic leukemia of the cat. J Natl Cancer Inst (1969) 2.66
Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. Proc Natl Acad Sci U S A (1987) 2.53
Ribonucleic acid components of BAI strain A (myeloblastosis) avian tumor virus. Cancer Res (1967) 2.53
Polypeptides of avian RNA tumor viruses. 1. Isolation and physical and chemical analysis. Virology (1970) 2.49
The free radical in pyruvate formate-lyase is located on glycine-734. Proc Natl Acad Sci U S A (1992) 2.30
Properties of mouse leukemia viruses. 3. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching. Virology (1972) 2.26
Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect Immun (1997) 2.24
Isolation of the major viral glycoprotein and a putative precursor from cells transformed by avian sarcoma viruses. Proc Natl Acad Sci U S A (1974) 2.15
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
Implementation of the quality management system improves postoperative pain treatment: a prospective pre-/post-interventional questionnaire study. Br J Anaesth (2012) 2.09
Polypeptides of avian RNA tumor viruses. IV. Components of the viral envelope. Virology (1972) 2.09
Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones. Biochimie (1994) 2.07
Di-myo-inositol-1,1'-phosphate: a new inositol phosphate isolated from Pyrococcus woesei. FEBS Lett (1992) 2.06
The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1992) 2.00
Cloning and analysis of the mating type genes from Cochliobolus heterostrophus. Mol Gen Genet (1993) 1.99
Properties of mouse leukemia viruses. VIII. The major viral glycoprotein of Friend leukemia virus. Seroimmunological, interfering and hemagglutinating capacities. Virology (1974) 1.98
A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. Proc Natl Acad Sci U S A (1987) 1.87
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy. AIDS (1998) 1.81
One enzyme makes a fungal pathogen, but not a saprophyte, virulent on a new host plant. Science (1989) 1.80
Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation. J Cell Biol (1994) 1.80
Nucleotide sequence analysis of the gene encoding the Deinococcus radiodurans surface protein, derived amino acid sequence, and complementary protein chemical studies. J Bacteriol (1987) 1.74
Neutralization of homologous and heterologous oncornaviruses by antisera against the p15(E) and gp71 polypeptides of Friend murine leukemia virus. Virology (1976) 1.73
Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol (1998) 1.70
Evidence that a precursor glycoprotein is cleaved to yield the major glycoprotein of avian tumor virus. J Virol (1977) 1.70
Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch Microbiol (2000) 1.70
Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells. Proc Natl Acad Sci U S A (1987) 1.70
Isolation of proteins by gel filtration in 6M guanidinium chloride: application to RNA tumor viruses. Anal Biochem (1974) 1.70
[Production of substantial amounts of Friend leukemia virus by a suspension tissue culture line (Eveline suspension cells) (author's transl)]. Z Naturforsch C (1976) 1.69
Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol (1999) 1.69
Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies. J Immunol (1990) 1.68
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. J Infect Dis (1993) 1.67
Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines. J Exp Med (1988) 1.67
CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res Hum Retroviruses (1993) 1.66
An analysis of type-C retrovirus polypeptides and their associations in the virion. Virology (1978) 1.65
Comparative chemical properties of avian oncornavirus polypeptides. Virology (1975) 1.64
Polypeptides of mammalian oncornaviruses. II Characterization of murine leukemia virus polypeptide (p 15) bearing interspecies reactivity. Virology (1975) 1.63
Studies on mouse leukemia viruses. I. Isolation and characterization of a group-specific antigen. Virology (1969) 1.63
Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. J Immunol (1989) 1.63
Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin. Virology (1995) 1.60
Polypeptides of mammalian oncornaviruses. I. Isolation and serological analysis polypeptides from murine and feline C-type viruses. Virology (1973) 1.59
Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J Infect Dis (1999) 1.58
HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J Immunol (1989) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Purification and serological characterization of the major envelope glycoprotein from AKR murine leukemia virus and its reactivity with autogenous immune sera from mice. J Virol (1976) 1.56
Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas. Proc Natl Acad Sci U S A (1974) 1.54
Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. Circulation (2000) 1.54
Signal transduction in Halobacterium depends on fumarate. EMBO J (1990) 1.52
Polypeptides of avian RNA tumor viruses. V. Analysis of the virus core. Virology (1972) 1.51
[Intraoperative cholangiography as a routine method? A prospective, controlled, randomized study]. Chirurg (1997) 1.50
Transperineal ultrasound imaging in prolonged second stage of labor with occipitoanterior presenting fetuses: how well does the 'angle of progression' predict the mode of delivery? Ultrasound Obstet Gynecol (2009) 1.49
Documenting community-level outcomes. Lessons from drinking and driving. Eval Rev (1997) 1.49
Polypeptides of mammalian oncornaviruses. III. Localization of p 15 and reactivity with natural antibody. Virology (1975) 1.48
Expression of the Major Viral Glycoprotein of Avian Tumor Virus in Cells of chf(+) Chicken Embryos. J Virol (1975) 1.48
Cutinase is not required for fungal pathogenicity on pea. Plant Cell (1992) 1.48
Properties of mouse leukemia viruses. X. Occurrence of viral structural antigens on the cell surface as revealed by a cytotoxicity test. Virology (1976) 1.47
Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine. Proc Natl Acad Sci U S A (1987) 1.46
A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy. J Infect Dis (1999) 1.46
Origin of group-specific antigen of chicken leukosis viruses. Virology (1966) 1.44
Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage. J Virol (1998) 1.43
Endoproteolytic cleavage of its propeptide is a prerequisite for efficient transport of furin out of the endoplasmic reticulum. J Biol Chem (1995) 1.43
Empyema of the thorax due to Gemella haemolysans. J Infect (1999) 1.43
Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virus. Virology (1978) 1.42
Idiopathic segmental infarction of the greater omentum successfully treated by laparoscopy: report of case. Surg Today (2000) 1.41
Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses. J Immunol (1980) 1.41
Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. Proc Natl Acad Sci U S A (1983) 1.41
[Is physiotherapy useful following surgery for carpal tunnel syndrome?]. Z Orthop Ihre Grenzgeb (1996) 1.39
Scoring the short form ICSmaleSF questionnaire. International Continence Society. J Urol (2000) 1.39
C-type particles produced by a permanent cell line from a leukemic pig. I. Origin and properties of the host cells and some evidence for the occurrence of C-type-like particles. Virology (1974) 1.38
Evaluation of canines for accelerant detection at fire scenes. J Forensic Sci (1994) 1.38
Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals. Lancet (1988) 1.38
Structural components of rna tumor viruses. Adv Virus Res (1974) 1.37
Properties of mouse leukemia viruses. IX. Active and passive immunization of mice against Friend leukemia with isolated viral GP71 glycoprotein and its corresponding antiserum. Virology (1975) 1.37
Oncogenic and immunogenic potential of cloned HIX virus in mice and cats. Med Microbiol Immunol (1977) 1.37
Ran-binding protein 5 (RanBP5) is related to the nuclear transport factor importin-beta but interacts differently with RanBP1. Mol Cell Biol (1997) 1.36
Polypeptides of avian RNA tumor viruses. II. Serological characterization. Virology (1970) 1.32